The company said it expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve its US sales.

J B Chemicals & Pharmaceuticals manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs). The firm's business segments include domestic formulation business, exports and API business.

% On a consolidated basis, the company's net profit declined 21.1% to Rs 73.82 crore on a 2.8% decline in net sales to Rs 443.56 crore in Q2 September 2020 over Q2 September 2019.